# Woodsmoke Particulate + Prednisone

> **NCT03861390** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 12 (actual)

## Conditions studied

- Airway Inflammation

## Interventions

- **DRUG:** 60 mg Prednisone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03861390
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-22
- **Primary completion:** 2023-05-12
- **Final completion:** 2023-05-12
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2024-06-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03861390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03861390, "Woodsmoke Particulate + Prednisone". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03861390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*